The currently recommended five-day course of molnupiravir, an antiviral treatment, may not be long enough to treat COVID-19, according to a new paper involving Professor Joseph Standing (Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Great Ormond Street Institute of Child Health).
, , Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø News